Single Ascending Dose Study for Evaluation of Safety, Tolerability and Pharmacokinetics of L606

Summary

The primary objective of this study is to evaluate the Pharmacokinetics, Safety and Tolerability of L606 (Liposomal Treprostinil) Inhalation Solution in Single Ascending Dose study design in healthy volunteers.

Timeline

Start

2018-11-09

Primary completion

2019-09-20

Completion

2020-05-12

Drugs

Indications